Advertisement

Metabolic Brain Disease

, Volume 27, Issue 4, pp 567–572 | Cite as

A patients’ and caregivers’ perspective on hepatic encephalopathy

  • S. Montagnese
  • E. Amato
  • S. Schiff
  • S. Facchini
  • P. Angeli
  • A. Gatta
  • P. Amodio
Original Paper

Abstract

Awareness of previous hepatic encephalopathy (HE) and compliance with treatment can probably reduce HE recurrence. The aim of this study was to assess the degree of awareness of previous HE and its treatment in a group of cirrhotic patients and their caregivers. Thirty-five cirrhotic patients with a history of HE and their caregivers (n = 31) were enrolled. Patients underwent evaluation of HE (clinical, psychometry and electroencephalography), quality of life (SF36 questionnaire), and awareness of HE/treatment on an ad hoc questionnaire (QAE). Caregivers underwent the QAE plus the Caregiver Burden Inventory. On the day of study, 7 patients were unimpaired, 8 had minimal and 20 low-grade overt HE. Of the patients, 37 % were aware of previous HE, 6 % of being on treatment and 6 % understood treatment effects. Of the caregivers, 48 % were aware of previous HE, 6 % of their relative being on treatment and 6 % understood treatment effects. Significant correlations were observed between neuropsychiatric status/linear HE indices and both the patients’ quality of life and the caregivers’ burden. In conclusion, HE awareness was poor in both patients and caregivers, most likely in relation to insufficient/inadequate provision of information.

Keywords

Cirrhosis Hepatic encephalopathy Education Information Compliance 

Notes

No financial support

No conflicts of interest

References

  1. Amodio P, Marchetti P, Del Piccolo F et al (1999) Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 110:1334–1344PubMedCrossRefGoogle Scholar
  2. Amodio P, Campagna F, Olianas S et al (2008) Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 49:346–353PubMedCrossRefGoogle Scholar
  3. Bajaj JS, Schubert CM, Heuman DM et al (2010) Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 138:2332–2340PubMedCrossRefGoogle Scholar
  4. Conn HO, Leevy CM, Vlahcevic ZR et al (1977) Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 72:573–583PubMedGoogle Scholar
  5. Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721PubMedCrossRefGoogle Scholar
  6. Groeneweg M, Quero JC, De Bruijn I et al (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49PubMedCrossRefGoogle Scholar
  7. Montagnese S, Biancardi A, Schiff S et al (2011) Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 53:558–566PubMedCrossRefGoogle Scholar
  8. Novak M, Guest C (1989) Application of a multidimensional caregiver burden inventory. Gerontologist 29:798–803PubMedCrossRefGoogle Scholar
  9. Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45:549–559PubMedCrossRefGoogle Scholar
  10. Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649PubMedCrossRefGoogle Scholar
  11. Riggio O, Efrati C, Catalano C et al (2005) High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology 42:1158–1165PubMedCrossRefGoogle Scholar
  12. Riggio O, Ridola L, Pasquale C et al (2011) Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 9:181–183PubMedCrossRefGoogle Scholar
  13. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483PubMedCrossRefGoogle Scholar
  14. Weissenborn K, Ennen JC, Schomerus H et al (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • S. Montagnese
    • 1
  • E. Amato
    • 1
  • S. Schiff
    • 1
  • S. Facchini
    • 1
  • P. Angeli
    • 1
  • A. Gatta
    • 1
  • P. Amodio
    • 1
  1. 1.Department of MedicineUniversity of PadovaPadovaItaly

Personalised recommendations